Is rivaroxaban associated with higher morbidity and mortality in patients with traumatic head injuries?

Autor:	Jentzsch, Thorsten, Moos, Rudolf M., Neuhaus, Valentin, Hussein, Kariem, Farei-Campagna, Jan, Seifert, Burkhardt, Simmen, Hans-Peter, Osterhoff, Georg
Jazyk:	angličtina
Rok vydání:	2018
Předmět:	ddc: 610 phenprocoumon anticoagulant morbidity 610 Medical sciences Medicine Traumatic brain injury (TBI) mortality rivaroxaban
Zdroj:	Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2018); 20181023-20181026; Berlin; DOCPT24-1339 /20181106/
Popis:	Objectives: Traumatic brain injuries are common. The projected incidence varies by age and ranges between 13-23%. The associated mortality rate is approximately 3%. Rivaroxaban is a new anticoagulant that acts as a direct factor Xa inhibitor. It does not to be monitored with laboratory assessments[for full text, please go to the a.m. URL] Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2018)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f8f838ebff651823ab4b4eaca88004 http://nbn-resolving.de/urn:nbn:de:0183-18dkou7694 Zobrazit plný text záznamu